Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for AURA

Stock Name	Aura Energy Ltd
Ticker	AURA(GBX) LSE
TYPE	Common Stock
Country	UK
ISIN	AU000000AEE7

Show aggregate AURA holdings

News associated with AURA

Aura Biosciences (NASDAQ:AURA) Stock Rating Upgraded by Zacks Research: Zacks Research upgraded shares of Aura Biosciences (NASDAQ:AURA – Free Report) from a strong sell rating to a hold rating in a research note published on Tuesday morning,Zacks.com reports. Several other brokerages have also weighed in on AURA. JMP Securities restated a “market outperform” rating and issued a $19.00 price target on shares of Aura […] - 2025-08-22 02:24:45
4 Artificial Intelligence Stocks (That Aren't Nvidia) You Can Buy and Hold for the Next Decade: Key PointsMeta Platforms is leveraging its massive user base to develop and test new AI products, aiming to maintain its leadership in social media and capitalize on future growth. - 2025-07-29 17:53:00
Analysts Set Aura Biosciences, Inc. (NASDAQ:AURA) PT at $22.00: Shares of Aura Biosciences, Inc. (NASDAQ:AURA – Get Free Report) have earned a consensus rating of “Buy” from the eight research firms that are covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month […] - 2025-07-25 05:10:56
Alps Advisors Inc. Has $218,000 Stake in Aura Biosciences, Inc. (NASDAQ:AURA): Alps Advisors Inc. trimmed its position in shares of Aura Biosciences, Inc. (NASDAQ:AURA – Free Report) by 8.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 37,156 shares of the company’s stock after selling 3,236 shares during the quarter. Alps Advisors Inc.’s holdings in Aura Biosciences were worth $218,000 at the end […] - 2025-07-18 05:53:05
Two Sigma Investments LP Sells 6,911 Shares of Aura Biosciences, Inc. (NASDAQ:AURA): Two Sigma Investments LP cut its stake in Aura Biosciences, Inc. (NASDAQ:AURA – Free Report) by 20.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 27,512 shares of the company’s stock after selling 6,911 shares during the quarter. Two Sigma Investments LP’s […] - 2025-06-12 05:05:02
Brokerages Set Aura Biosciences, Inc. (NASDAQ:AURA) PT at $22.00: Shares of Aura Biosciences, Inc. (NASDAQ:AURA – Get Free Report) have received an average recommendation of “Buy” from the eight ratings firms that are currently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average […] - 2025-06-03 03:07:01
HC Wainwright Upgrades Aura Biosciences (NASDAQ:AURA) to “Buy”: Aura Biosciences (NASDAQ:AURA – Get Free Report) was upgraded by research analysts at HC Wainwright to a “buy” rating in a note issued to investors on Wednesday, Marketbeat reports. The brokerage presently has a $22.00 price objective on the stock. HC Wainwright’s price objective suggests a potential upside of 261.25% from the stock’s current price. […] - 2025-05-30 02:21:01
JMP Securities Reiterates Market Outperform Rating for Aura Biosciences (NASDAQ:AURA): JMP Securities reissued their market outperform rating on shares of Aura Biosciences (NASDAQ:AURA – Free Report) in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a $19.00 price target on the stock. Several other research analysts also recently commented on the company. Citigroup reaffirmed an “outperform” rating on shares of […] - 2025-05-26 02:12:52
Aura Biosciences, Inc. (NASDAQ:AURA) Receives $22.75 Average Price Target from Brokerages: Aura Biosciences, Inc. (NASDAQ:AURA – Get Free Report) has received a consensus recommendation of “Buy” from the eight ratings firms that are currently covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1 year […] - 2025-05-09 02:40:52
Geode Capital Management LLC Has $8.33 Million Stake in Aura Biosciences, Inc. (NASDAQ:AURA): Geode Capital Management LLC raised its position in shares of Aura Biosciences, Inc. (NASDAQ:AURA – Free Report) by 0.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,012,799 shares of the company’s stock after acquiring an additional 3,972 shares during the […] - 2025-04-24 04:32:52
Aura Biosciences, Inc. (NASDAQ:AURA) Sees Significant Increase in Short Interest: Aura Biosciences, Inc. (NASDAQ:AURA – Get Free Report) was the recipient of a large increase in short interest in March. As of March 31st, there was short interest totalling 1,420,000 shares, an increase of 19.3% from the March 15th total of 1,190,000 shares. Approximately 3.2% of the shares of the stock are short sold. Based […] - 2025-04-23 03:13:08
Wellington Management Group LLP Grows Holdings in Aura Biosciences, Inc. (NASDAQ:AURA): Wellington Management Group LLP boosted its position in Aura Biosciences, Inc. (NASDAQ:AURA – Free Report) by 12.6% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 131,054 shares of the company’s stock after purchasing an additional 14,662 shares during the period. Wellington Management Group LLP’s holdings in […] - 2025-04-14 04:45:06
Brokerages Set Aura Biosciences, Inc. (NASDAQ:AURA) Price Target at $22.75: Shares of Aura Biosciences, Inc. (NASDAQ:AURA – Get Free Report) have received a consensus rating of “Buy” from the eight analysts that are currently covering the company, Marketbeat reports. Six investment analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1 year […] - 2025-04-14 02:59:02
Aura Biosciences, Inc. (NASDAQ:AURA) Sees Large Decrease in Short Interest: Aura Biosciences, Inc. (NASDAQ:AURA – Get Free Report) saw a significant decline in short interest during the month of February. As of February 28th, there was short interest totalling 1,120,000 shares, a decline of 13.2% from the February 13th total of 1,290,000 shares. Approximately 2.5% of the company’s shares are short sold. Based on an […] - 2025-03-21 04:27:01
AlphaQuest LLC Purchases New Shares in Aura Biosciences, Inc. (NASDAQ:AURA): AlphaQuest LLC purchased a new stake in Aura Biosciences, Inc. (NASDAQ:AURA – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 16,511 shares of the company’s stock, valued at approximately $136,000. A number of other hedge funds and other institutional investors have also modified their holdings of AURA. China Universal Asset […] - 2025-03-18 06:06:52

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) AURA holdings

Date	Number of AURA Shares Held	Base Market Value of AURA Shares	Local Market Value of AURA Shares	Change in AURA Shares Held	Change in AURA Base Value	Current Price per AURA Share Held	Previous Price per AURA Share Held

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AURA by Blackrock for IE00BYXG2H39

Show aggregate share trades of AURA

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-10-06 BUY 333 5.920 6.140 6.118 GBX 2,037 6.63
2025-10-03 BUY 770 6.050 6.283 6.260 GBX 4,820 6.63
2025-10-02 BUY 110 6.020 6.170 6.155 GBX 677 6.63
2025-09-30 BUY 220 6.180 6.250 6.243 GBX 1,373 6.64
2025-09-26 BUY 220 6.160 6.180 6.178 GBX 1,359 6.64
2025-09-25 BUY 220 5.880 6.270 6.231 GBX 1,371 6.65
2025-09-18 BUY 111 6.260 6.400 6.386 GBX 709 6.65
2025-09-17 BUY 333 6.100 6.400 6.370 GBX 2,121 6.65
2025-09-11 SELL -110 6.640 6.670 6.667 GBX -733 6.66 Loss of 0 on sale
2025-09-10 BUY 222 6.440 6.530 6.521 GBX 1,448 6.66
2025-09-05 SELL -110 6.480 6.560 6.552 GBX -721 6.67 Profit of 13 on sale
2025-08-29 SELL -333 6.260 6.485 6.463 GBX -2,152 6.68 Profit of 71 on sale
2025-08-27 BUY 220 6.440 6.721 6.693 GBX 1,472 6.68
2025-08-26 SELL -110 6.500 6.800 6.770 GBX -745 6.68 Loss of -10 on sale
2025-08-25 BUY 110 6.520 6.600 6.592 GBX 725 6.68
2025-08-20 SELL -436 6.370 6.410 6.406 GBX -2,793 6.69 Profit of 122 on sale
2025-08-18 BUY 216 6.690 6.800 6.789 GBX 1,466 6.69
2025-08-08 SELL -216 6.800 6.830 6.827 GBX -1,475 6.68 Loss of -32 on sale
2025-08-05 BUY 108 6.630 7.020 6.981 GBX 754 6.68
2025-08-01 SELL -323 6.740 6.870 6.857 GBX -2,215 6.68 Loss of -58 on sale
2025-07-30 BUY 432 6.590 6.980 6.941 GBX 2,999 6.68
2025-07-17 SELL -216 7.120 7.151 7.148 GBX -1,544 6.66 Loss of -105 on sale
2025-07-11 SELL -872 6.400 6.785 6.746 GBX -5,883 6.66 Loss of -76 on sale
2025-07-07 BUY 327 6.160 6.470 6.439 GBX 2,106 6.67
2025-07-02 BUY 5,995 6.460 6.720 6.694 GBX 40,131 6.67
2025-06-25 BUY 218 6.570 6.675 6.665 GBX 1,453 6.68
2025-06-20 BUY 8,163 6.040 6.180 6.166 GBX 50,333 6.69
2025-06-11 BUY 162 6.630 7.120 7.071 GBX 1,146 6.71
2025-06-10 BUY 162 6.970 7.010 7.006 GBX 1,135 6.71
2025-06-04 SELL -81 6.140 6.500 6.464 GBX -524 6.73 Profit of 21 on sale
2025-04-23 BUY 81 5.760 5.920 5.904 GBX 478 7.13
2025-04-10 SELL -648 4.970 5.210 5.186 GBX -3,361 7.36 Profit of 1,410 on sale
2025-04-08 SELL -81 5.230 5.990 5.914 GBX -479 7.43 Profit of 123 on sale
2025-04-07 SELL -81 5.520 5.600 5.592 GBX -453 7.46 Profit of 151 on sale
2025-04-04 SELL -405 5.430 5.740 5.709 GBX -2,312 7.49 Profit of 721 on sale
2025-04-01 BUY 324 5.670 5.870 5.850 GBX 1,895 7.55
2025-03-31 SELL -243 5.860 6.455 6.395 GBX -1,554 7.57 Profit of 287 on sale
2025-03-14 SELL -1,296 7.350 7.630 7.602 GBX -9,852 7.71 Profit of 134 on sale
2025-03-07 SELL -162 7.400 7.500 7.490 GBX -1,213 7.75 Profit of 42 on sale
2025-03-04 SELL -81 7.500 7.550 7.545 GBX -611 7.77 Profit of 18 on sale
2025-02-25 BUY 162 7.280 7.630 7.595 GBX 1,230 7.82
2025-02-19 SELL -81 7.650 7.785 7.771 GBX -629 7.86 Profit of 7 on sale
2025-02-13 BUY 243 7.940 8.040 8.030 GBX 1,951 7.86
2025-02-12 BUY 81 7.920 7.990 7.983 GBX 647 7.86
2025-02-11 BUY 324 7.730 7.730 7.730 GBX 2,505 7.86
2025-01-17 BUY 324 7.770 7.900 7.887 GBX 2,555 7.77
2025-01-16 BUY 324 7.670 7.800 7.787 GBX 2,523 7.78
2025-01-10 SELL -162 7.600 7.910 7.879 GBX -1,276 8.02 Profit of 23 on sale
2025-01-08 SELL -324 7.900 8.060 8.044 GBX -2,606 8.26 Profit of 70 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-10-06	BUY	333	5.920	6.140	6.118	GBX 2,037	6.63
2025-10-03	BUY	770	6.050	6.283	6.260	GBX 4,820	6.63
2025-10-02	BUY	110	6.020	6.170	6.155	GBX 677	6.63
2025-09-30	BUY	220	6.180	6.250	6.243	GBX 1,373	6.64
2025-09-26	BUY	220	6.160	6.180	6.178	GBX 1,359	6.64
2025-09-25	BUY	220	5.880	6.270	6.231	GBX 1,371	6.65
2025-09-18	BUY	111	6.260	6.400	6.386	GBX 709	6.65
2025-09-17	BUY	333	6.100	6.400	6.370	GBX 2,121	6.65
2025-09-11	SELL	-110	6.640	6.670	6.667	GBX -733	6.66 Loss of 0 on sale
2025-09-10	BUY	222	6.440	6.530	6.521	GBX 1,448	6.66
2025-09-05	SELL	-110	6.480	6.560	6.552	GBX -721	6.67 Profit of 13 on sale
2025-08-29	SELL	-333	6.260	6.485	6.463	GBX -2,152	6.68 Profit of 71 on sale
2025-08-27	BUY	220	6.440	6.721	6.693	GBX 1,472	6.68
2025-08-26	SELL	-110	6.500	6.800	6.770	GBX -745	6.68 Loss of -10 on sale
2025-08-25	BUY	110	6.520	6.600	6.592	GBX 725	6.68
2025-08-20	SELL	-436	6.370	6.410	6.406	GBX -2,793	6.69 Profit of 122 on sale
2025-08-18	BUY	216	6.690	6.800	6.789	GBX 1,466	6.69
2025-08-08	SELL	-216	6.800	6.830	6.827	GBX -1,475	6.68 Loss of -32 on sale
2025-08-05	BUY	108	6.630	7.020	6.981	GBX 754	6.68
2025-08-01	SELL	-323	6.740	6.870	6.857	GBX -2,215	6.68 Loss of -58 on sale
2025-07-30	BUY	432	6.590	6.980	6.941	GBX 2,999	6.68
2025-07-17	SELL	-216	7.120	7.151	7.148	GBX -1,544	6.66 Loss of -105 on sale
2025-07-11	SELL	-872	6.400	6.785	6.746	GBX -5,883	6.66 Loss of -76 on sale
2025-07-07	BUY	327	6.160	6.470	6.439	GBX 2,106	6.67
2025-07-02	BUY	5,995	6.460	6.720	6.694	GBX 40,131	6.67
2025-06-25	BUY	218	6.570	6.675	6.665	GBX 1,453	6.68
2025-06-20	BUY	8,163	6.040	6.180	6.166	GBX 50,333	6.69
2025-06-11	BUY	162	6.630	7.120	7.071	GBX 1,146	6.71
2025-06-10	BUY	162	6.970	7.010	7.006	GBX 1,135	6.71
2025-06-04	SELL	-81	6.140	6.500	6.464	GBX -524	6.73 Profit of 21 on sale
2025-04-23	BUY	81	5.760	5.920	5.904	GBX 478	7.13
2025-04-10	SELL	-648	4.970	5.210	5.186	GBX -3,361	7.36 Profit of 1,410 on sale
2025-04-08	SELL	-81	5.230	5.990	5.914	GBX -479	7.43 Profit of 123 on sale
2025-04-07	SELL	-81	5.520	5.600	5.592	GBX -453	7.46 Profit of 151 on sale
2025-04-04	SELL	-405	5.430	5.740	5.709	GBX -2,312	7.49 Profit of 721 on sale
2025-04-01	BUY	324	5.670	5.870	5.850	GBX 1,895	7.55
2025-03-31	SELL	-243	5.860	6.455	6.395	GBX -1,554	7.57 Profit of 287 on sale
2025-03-14	SELL	-1,296	7.350	7.630	7.602	GBX -9,852	7.71 Profit of 134 on sale
2025-03-07	SELL	-162	7.400	7.500	7.490	GBX -1,213	7.75 Profit of 42 on sale
2025-03-04	SELL	-81	7.500	7.550	7.545	GBX -611	7.77 Profit of 18 on sale
2025-02-25	BUY	162	7.280	7.630	7.595	GBX 1,230	7.82
2025-02-19	SELL	-81	7.650	7.785	7.771	GBX -629	7.86 Profit of 7 on sale
2025-02-13	BUY	243	7.940	8.040	8.030	GBX 1,951	7.86
2025-02-12	BUY	81	7.920	7.990	7.983	GBX 647	7.86
2025-02-11	BUY	324	7.730	7.730	7.730	GBX 2,505	7.86
2025-01-17	BUY	324	7.770	7.900	7.887	GBX 2,555	7.77
2025-01-16	BUY	324	7.670	7.800	7.787	GBX 2,523	7.78
2025-01-10	SELL	-162	7.600	7.910	7.879	GBX -1,276	8.02 Profit of 23 on sale
2025-01-08	SELL	-324	7.900	8.060	8.044	GBX -2,606	8.26 Profit of 70 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AURA

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	40,870	0	79,597	51.3%
2025-09-18	41,449	0	164,098	25.3%
2025-09-17	27,679	1,174	71,477	38.7%
2025-09-16	42,150	2,986	184,371	22.9%
2025-09-15	21,123	18	48,502	43.6%
2025-09-12	24,725	0	74,058	33.4%
2025-09-11	18,911	7,199	109,257	17.3%
2025-09-10	21,489	4,276	81,079	26.5%
2025-09-09	18,027	1,458	48,260	37.4%
2025-09-08	24,727	2,894	115,919	21.3%
2025-09-05	11,019	3,138	55,535	19.8%
2025-09-04	15,392	6,321	38,626	39.8%
2025-09-03	18,408	7,077	52,059	35.4%
2025-09-02	20,888	0	51,133	40.9%
2025-08-29	8,944	0	32,341	27.7%
2025-08-28	6,532	0	45,985	14.2%
2025-08-27	15,504	0	48,545	31.9%
2025-08-26	15,485	2,077	41,978	36.9%
2025-08-25	26,738	4,754	60,053	44.5%
2025-08-22	24,241	8,853	72,204	33.6%
2025-08-21	23,625	6,765	84,509	28.0%
2025-08-20	38,574	4,685	51,234	75.3%
2025-08-19	22,019	2,456	35,265	62.4%
2025-08-18	24,434	5,603	43,538	56.1%
2025-08-15	11,573	518	22,594	51.2%
2025-08-14	27,823	7,517	44,551	62.5%
2025-08-13	29,225	6,060	93,732	31.2%
2025-08-12	34,871	100	44,654	78.1%
2025-08-11	24,294	6,006	28,356	85.7%
2025-08-08	27,709	3,538	38,732	71.5%
2025-08-07	17,985	6	30,171	59.6%
2025-08-06	33,584	94	41,197	81.5%
2025-08-05	35,499	0	52,293	67.9%
2025-08-04	24,575	2,400	90,569	27.1%
2025-08-01	69,597	0	102,883	67.6%
2025-07-31	37,330	2,708	62,486	59.7%
2025-07-30	39,860	826	55,733	71.5%
2025-07-29	84,233	0	99,033	85.1%
2025-07-28	110,522	15	128,467	86.0%
2025-07-25	31,207	0	53,797	58.0%
2025-07-24	45,499	2,846	58,761	77.4%
2025-07-23	58,180	1,900	85,122	68.3%
2025-07-22	10,980	0	23,993	45.8%
2025-07-21	36,824	3,478	69,140	53.3%
2025-07-18	56,436	0	92,287	61.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE